Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.16 USD
−63.69 M USD
25.98 M USD
26.18 M
About Whitehawk Therapeutics, Inc.
Sector
Industry
CEO
David Lennon
Website
Headquarters
Morristown
Founded
2007
FIGI
BBG002WN7DT2
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of WHWK is 1.74 USD — it has decreased by −0.57% in the past 24 hours. Watch Whitehawk Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Whitehawk Therapeutics, Inc. stocks are traded under the ticker WHWK.
WHWK stock has fallen by −12.61% compared to the previous week, the month change is a −6.95% fall, over the last year Whitehawk Therapeutics, Inc. has showed a 13.73% increase.
We've gathered analysts' opinions on Whitehawk Therapeutics, Inc. future price: according to them, WHWK price has a max estimate of 2.00 USD and a min estimate of 2.00 USD. Watch WHWK chart and read a more detailed Whitehawk Therapeutics, Inc. stock forecast: see what analysts think of Whitehawk Therapeutics, Inc. and suggest that you do with its stocks.
WHWK reached its all-time high on Sep 18, 2017 with the price of 1,518.75 USD, and its all-time low was 1.21 USD and was reached on Aug 8, 2024. View more price dynamics on WHWK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
WHWK stock is 5.81% volatile and has beta coefficient of 0.60. Track Whitehawk Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Whitehawk Therapeutics, Inc. there?
Today Whitehawk Therapeutics, Inc. has the market capitalization of 81.97 M, it has decreased by −1.02% over the last week.
Yes, you can track Whitehawk Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Whitehawk Therapeutics, Inc. is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
WHWK earnings for the last quarter are 1.83 USD per share, whereas the estimation was −0.46 USD resulting in a 497.83% surprise. The estimated earnings for the next quarter are 0.82 USD per share. See more details about Whitehawk Therapeutics, Inc. earnings.
Whitehawk Therapeutics, Inc. revenue for the last quarter amounts to 7.14 M USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 50.00 M USD.
WHWK net income for the last quarter is 73.02 M USD, while the quarter before that showed −18.27 M USD of net income which accounts for 499.58% change. Track more Whitehawk Therapeutics, Inc. financial stats to get the full picture.
No, WHWK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 3, 2025, the company has 40 employees. See our rating of the largest employees — is Whitehawk Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Whitehawk Therapeutics, Inc. EBITDA is −60.33 M USD, and current EBITDA margin is −248.73%. See more stats in Whitehawk Therapeutics, Inc. financial statements.
Like other stocks, WHWK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Whitehawk Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Whitehawk Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Whitehawk Therapeutics, Inc. stock shows the sell signal. See more of Whitehawk Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.